- Home
- RRGB vs STRO Comparison
RRGB vs STRO Comparison
Compare RRGB & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRGB
- STRO
- Stock Information
- Founded
- RRGB 1969
- STRO 2003
- Country
- RRGB United States
- STRO United States
- Employees
- RRGB N/A
- STRO N/A
- Industry
- RRGB Restaurants
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RRGB Consumer Discretionary
- STRO Health Care
- Exchange
- RRGB Nasdaq
- STRO Nasdaq
- Market Cap
- RRGB 88.7M
- STRO 77.7M
- IPO Year
- RRGB 2002
- STRO 2018
- Fundamental
- Price
- RRGB $6.30
- STRO $0.70
- Analyst Decision
- RRGB Strong Buy
- STRO Hold
- Analyst Count
- RRGB 4
- STRO 7
- Target Price
- RRGB $11.88
- STRO $3.97
- AVG Volume (30 Days)
- RRGB 620.3K
- STRO 1.4M
- Earning Date
- RRGB 08-21-2025
- STRO 08-12-2025
- Dividend Yield
- RRGB N/A
- STRO N/A
- EPS Growth
- RRGB N/A
- STRO N/A
- EPS
- RRGB N/A
- STRO N/A
- Revenue
- RRGB $1,252,370,000.00
- STRO $66,434,000.00
- Revenue This Year
- RRGB $0.04
- STRO N/A
- Revenue Next Year
- RRGB N/A
- STRO N/A
- P/E Ratio
- RRGB N/A
- STRO N/A
- Revenue Growth
- RRGB N/A
- STRO N/A
- 52 Week Low
- RRGB $2.50
- STRO $0.52
- 52 Week High
- RRGB $7.66
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- RRGB 65.37
- STRO 37.20
- Support Level
- RRGB $5.41
- STRO $0.67
- Resistance Level
- RRGB $6.48
- STRO $0.87
- Average True Range (ATR)
- RRGB 0.43
- STRO 0.07
- MACD
- RRGB 0.02
- STRO -0.01
- Stochastic Oscillator
- RRGB 89.94
- STRO 11.85
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.